SUPERSTRING CAPITAL MANAGEMENT LP URGN Holdings History
SUPERSTRING CAPITAL MANAGEMENT LP's UroGen Pharma Ltd Holding Summary
As of 2025-03-31, SUPERSTRING CAPITAL MANAGEMENT LP held 423,632.00 shares of UroGen Pharma Ltd(URGN), totaling $4.69 Mil. This investment constitutes 5.57% of their stock portfolio, and SUPERSTRING CAPITAL MANAGEMENT LP now holds 0.92% of the outstanding UroGen Pharma Ltd(URGN) stock.
The initial trade took place in 2023Q4. And since then SUPERSTRING CAPITAL MANAGEMENT LP has made 3 purchases of URGN, at an average price of $12.30, for a total of 711,899.00 shares. In addition, there have been 1 sales at an average price of $14.22 for 288,267.00 shares. Based on historical transaction data and URGN's current price of $13.58, SUPERSTRING CAPITAL MANAGEMENT LP's estimated gain on his URGN holdings is $1.09 Mil, reflecting a 12.47% gain to date.
SUPERSTRING CAPITAL MANAGEMENT LP URGN ($13.58) Holding Chart
SUPERSTRING CAPITAL MANAGEMENT LP URGN ($13.58) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1